VRTX
Vertex Pharmaceuticals
Description:
Vertex Pharmaceuticals Inc. is a premier biopharmaceutical company based in Boston, Massachusetts, dedicated to pioneering transformative therapies for serious diseases, with a primary focus on cystic fibrosis (CF). The company has established itself as a leader in the industry through its groundbreaking therapies that have significantly enhanced the quality of life for patients with CF. Beyond its current successes, Vertex is expanding its R&D initiatives into additional therapeutic areas, underscoring its commitment to innovation and addressing unmet medical needs. With a robust financial standing and a strategic focus on growth, Vertex is poised to continue delivering value and advancing healthcare solutions in a dynamic market.
Address:
50 NORTHERN AVENUE, BOSTON, MA, UNITED STATES, 02210
Fiscal year end:
December
Market capitalization:
$119 Billion
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
+260%
How much will you get:
$3,603
Prices dates:
31-12-2015: $125.83 and 31-12-2025: $453.36